Skip to main content
Home
TERUMO GLOBAL
Home
TERUMO GLOBAL
  • About Terumo
    About Terumo
      • Dear Stakeholders
      • Group Mission
      • Who We Are
      • Corporate Governance
      • Compliance
      • Regulations and Standards
      • Procurement Activity
      • At a Glance
      • Leadership Team
      • History
      • Brand Video "Our Promise"
      • Terumo's Response to COVID-19
      • Education and Training
      • Terumo Ventures
  • Business Overview
    Business Overview
      • Terumo Interventional Systems
      • Terumo Neuro
      • Terumo Cardiovascular / HeartSheet Division
      • Terumo Aortic
      • Hospital Care Solutions
      • Life Care Solutions
      • Pharmaceutical Solutions
      • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
  • Sustainability
    Sustainability
      • Sustainability News
      • Sustainability at the Terumo Group
      • GRI Standards Index
  • Technology
    Technology
      • From Devices to Solutions
      • Basic Information
          • Basic Information Top
          • Research and Development
          • Production and Supply
          • Intellectual Property
          • Terumo Fellows
      • Stories - Our Technologies
  • Investors
    Investors
      • Management Policy
          • Management Policy
          • Top Management Message
          • Business Risks
          • Disclaimer
          • IR Policy
      • Financial Highlights
      • IR Library
          • IR Library
          • Financial Statements
          • Presentations
          • Consolidated Financial Statements
          • Terumo Reports
      • IR Events
      • Shareholders & Stock
          • Shareholders Meeting
          • Stock Information
          • Shareholder Return
          • Credit Ratings and Corporate Bond
          • Analyst Coverage
          • Articles of Incorporation
          • Site Quote
      • IR Inquiries
  • News
    News
      • May 27, 2025
        Corporate
        Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System

        – Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures –

      • May 14, 2025
        Financial
        Notice concerning differences in non-consolidated financial results between FY2023 and FY2024 (PDF 108.74 KB)
      • May 14, 2025
        Corporate
        Terumo Appoints the Candidates for Directors (PDF 139.55 KB)
    • Global Network
      Global Network
        • Japan
        • North America
        • South America
        • Europe, Middle East and Africa
        • Greater China
        • Asia and Pacific
    Select Region
    Show — Select Region Hide — Select Region
      • Regions/Countries
          • Japan
          • United States
              • Terumo Interventional Systems
              • Terumo Cardiovascular
              • Terumo Neuro
              • Terumo Blood and Cell Technologies
              • Terumo Aortic
              • Terumo Medical Products
              • Terumo Medical Corp
              • Terumo Health Outcomes
          • Canada
          • Europe
          • Latin America
              • Latin America
              • Mexico
              • Brazil
              • Colombia
              • Chile and Argentina
          • Asia Pacific
          • Australia
          • Korea
          • Vietnam
          • China
          • India
      • Global Business website
          • Terumo Cardiovascular
          • Terumo Aortic
          • Terumo Neuro
          • Terumo Blood and Cell Technologies
          • Pharmaceutical Solutions
    • About Terumo
      About Terumo
        • Dear Stakeholders
        • Group Mission
        • Who We Are
        • Corporate Governance
        • Compliance
        • Regulations and Standards
        • Procurement Activity
        • At a Glance
        • Leadership Team
        • History
        • Brand Video "Our Promise"
        • Terumo's Response to COVID-19
        • Education and Training
        • Terumo Ventures
    • Business Overview
      Business Overview
        • Terumo Interventional Systems
        • Terumo Neuro
        • Terumo Cardiovascular / HeartSheet Division
        • Terumo Aortic
        • Hospital Care Solutions
        • Life Care Solutions
        • Pharmaceutical Solutions
        • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
    • Sustainability
      Sustainability
        • Sustainability News
        • Sustainability at the Terumo Group
        • GRI Standards Index
    • Technology
      Technology
        • From Devices to Solutions
        • Basic Information
            • Basic Information Top
            • Research and Development
            • Production and Supply
            • Intellectual Property
            • Terumo Fellows
        • Stories - Our Technologies
    • Investors
      Investors
        • Management Policy
            • Management Policy
            • Top Management Message
            • Business Risks
            • Disclaimer
            • IR Policy
        • Financial Highlights
        • IR Library
            • IR Library
            • Financial Statements
            • Presentations
            • Consolidated Financial Statements
            • Terumo Reports
        • IR Events
        • Shareholders & Stock
            • Shareholders Meeting
            • Stock Information
            • Shareholder Return
            • Credit Ratings and Corporate Bond
            • Analyst Coverage
            • Articles of Incorporation
            • Site Quote
        • IR Inquiries
    • News
      News
        • May 27, 2025
          Corporate
          Terumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System

          – Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures –

        • May 14, 2025
          Financial
          Notice concerning differences in non-consolidated financial results between FY2023 and FY2024 (PDF 108.74 KB)
        • May 14, 2025
          Corporate
          Terumo Appoints the Candidates for Directors (PDF 139.55 KB)
      • Global Network
        Global Network
          • Japan
          • North America
          • South America
          • Europe, Middle East and Africa
          • Greater China
          • Asia and Pacific
      1. Home
      2. Investors
      3. Management Policy

      Management Policy

      Move to topTop
      Top Management Message
      Message from top management to shareholders and investors.
      /investors/management/message
      Top Management Message Image/Hikaru Samejima, Chief Executive Officer
      Corporate Governance
      /about/governance
      Image of Corporate Governance / Compass on the table
      Compliance
      /about/compliance
      Image of compliance / Business person shaking hands
      Leadership Team
      /about/leadership
      Image of the list of executives / Chairs lined up at the conference desk
      Business Risks
      Major risks that may affect the business performance and financial position of the Terumo Group are described.
      /investors/management/risk
      IR Policy
      /investors/management/ir_policy
      Disclaimer
      /investors/disclaimer
      Footer Menu
      Show — Footer Menu Hide — Footer Menu
        • About Terumo
            • About Terumo
            • Dear Stakeholders
            • Group Mission
            • Who We Are
            • Corporate Governance
            • Compliance
            • Regulations and Standards
            • Procurement Activity
            • At a Glance
            • Leadership Team
            • History
            • Brand Video "Our Promise"
            • Terumo's Response to COVID-19
            • Education and Training
            • Terumo Ventures
        • Business Overview
            • Business Overview
            • Terumo Interventional Systems
            • Terumo Neuro
            • Terumo Cardiovascular / HeartSheet Division
            • Terumo Aortic
            • Hospital Care Solutions
            • Life Care Solutions
            • Pharmaceutical Solutions
            • Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies)
        • Sustainability
            • Sustainability Overview
            • Sustainability News
            • Sustainability at the Terumo Group
            • GRI Standards Index
        • Technology
            • From Devices to Solutions
            • Technology Overview
            • Basic Information
                • Research and Development
                • Production and Supply
                • Intellectual Property
                • Terumo Fellows
            • Stories - Our Technologies
        • Investors
            • Investors
            • Management Policy
                • Top Management Message
                • Business Risks
                • Disclaimer
                • IR Policy
            • Financial Highlights
            • IR Library
                • Financial Statements
                • Presentations
                • Consolidated Financial Statements
                • Terumo Reports
            • IR Events
            • Shareholders & Stock
                • Shareholders Meeting
                • Stock Information
                • Shareholder Return
                • Credit Ratings and Corporate Bond
                • Analyst Coverage
                • Articles of Incorporation
                • Site Quote
            • IR Inquiries
        • News
            • News
            • Press Inquiries
        • Global Network
            • Japan
            • North America
            • South America
            • Europe, Middle East and Africa
            • Greater China
            • Asia and Pacific
      • About Terumo
      • Business Overview
      • Sustainability
      • Technology
      • Investors
      • News
      • Global Network
      Footer
      Show — Footer Hide — Footer
      • Terms and Conditions of Use
      • Privacy Policy
      • Cookie Policy
      • Cookie Settings
      • Social Media Policy
      • Site Map

      Copyright © 2025 Terumo Corporation, All Rights Reserved.